Subjects must be co-en rolled on protocol 03-C-0277. 2.1.2 Exclusion Criteria a. Women of child-bearing potentia l who are pregnant or breastfe eding because of the potentially dangerous effects of the treatment on the fetus or infant. b. Any form of primary immunodeficien cy (such as Severe Combined Immunodeficiency Disease). c.